VANCOUVER--(BUSINESS WIRE)--Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Noel Hall to its board of directors. Mr. Hall’s extensive knowledge of the biotechnology industry, along with his business-building experience, will significantly contribute to Zymeworks’ growth by guiding the development of its therapeutics pipeline.
